Difference between revisions of "Team:Lethbridge/Parts"

 
(33 intermediate revisions by 3 users not shown)
Line 4: Line 4:
 
{{Template:Lethbridge/mini-template-css}}
 
{{Template:Lethbridge/mini-template-css}}
 
<html>
 
<html>
 +
<style>
 +
.content table {background-color: white !important; color: black !important;}
 +
.content table a {color: black !important; text-decoration: underline !important;}
 +
</style>
 
<body>
 
<body>
 +
<br><br>
 +
<img src="https://static.igem.org/mediawiki/2018/c/c1/T--Lethbridge--banner_Parts.png" width=100% alt="Parts Banner Image">
 
<div class="content"> <!--everything added for content goes after this line-->
 
<div class="content"> <!--everything added for content goes after this line-->
−
<p>  
+
<br><br>
−
In order to explore the modularity and various applications of Protein Nanocompartments (PNCs), we have designed systems that have distinct PNCs, surface modifiers and carogs. Most PNCs are designed to have a specific surface modifying feature and cargo that look at different encapsulation strategies that are specific to these specific PNCs. </p>
+
  
−
<p>Each PNC system covers distinct applications for Research use. Each of our PNC systems is described in detail on our design page.</P> 
 
  
−
<p>There are several capsid proteins described in the registry, including the  <a href= "http://parts.igem.org/Part:BBa_K1442040">MS2 protein</a>. Our project diversified the capsid proteins available on the registry and are designed as composite parts under control of a T7 inducible promoter <a href= "http://parts.igem.org/Part:BBa_I712074">(BBa_I712074)</a> a medium strength RBS <a href= "http://parts.igem.org/Part:BBa_B0034" >(BBa_B0034)</a> and a double terminator <a href= "http://parts.igem.org/Part:BBa_B0015" >(BBa_B0015)</a> </p>
+
<div class="oneText-Wrapper">
 +
<div class="oneText-Text">
 +
    <p class="f12">In order to explore the modularity and various applications of Protein Nanocompartments (PNCs), we have designed systems that have distinct PNCs, surface modifiers, and cargos. Most PNCs are designed to have a specific surface modifying feature and cargo that look at different encapsulation strategies that are specific to these specific PNCs.</p>
 +
</div>
 +
</div>
 +
 
 +
<div style="clear: both"></div>
 +
 
 +
<div class="oneBlock-Wrapper">
 +
<div class="oneBlock-Block">
 +
<blockquote>Each PNC system covers distinct applications for Research use. Each of our PNC systems is described in detail on our design page.</blockquote> 
 +
</div>
 +
</div>
 +
 
 +
<div style="clear: both"></div>
 +
 
 +
<div class="oneText-Wrapper">
 +
<div class="oneText-Text">
 +
<p class="f12">There are several capsid proteins described in the registry, including the  <a href= "http://parts.igem.org/Part:BBa_K1442040"target="_blank">MS2 protein</a>. Our project diversified the capsid proteins available on the registry and are designed as composite parts under control of a T7 inducible promoter (<a href= "http://parts.igem.org/Part:BBa_I712074"target="_blank">BBa_I712074</a>) a medium strength RBS (<a href= "http://parts.igem.org/Part:BBa_J61100" target="_blank">BBa_J61100</a>) and a double terminator (<a href= "http://parts.igem.org/Part:BBa_B0014" target="_blank">BBa_B0014</a>).</p>
 +
</div>
 +
</div>
 +
 
 +
<div style="clear: both"></div>
 +
 
 
<h1> Parts Submitted:</h1>
 
<h1> Parts Submitted:</h1>
−
     <p>his year we were able to submit to the registry in the  pSB1C3 plasmid, the Arc minimal construct derived from HIV homology. This construct was theorized by our team this year. The Arc DNA sequence, originally from <a href= "https://www.uniprot.org/uniprot/Q63053">Rat</a> was compared to the HIV DNA sequence due to Arcs similarities to retrotransposons. This part is theorized to retain its abilities to form capsid structures and deliver RNA to cells. Our results can be found <a href= "https://2018.igem.org/Team:Lethbridge/Results">here</a> and the full design of this part can be found <a href= "https://2018.igem.org/Team:Lethbridge/Design">here</a>.
+
<div class="oneText-Wrapper">
−
We hope to finish cloning all of our designed parts for future studies and application.
+
<div class="oneText-Text">
−
</p>
+
     <p class="f12">This year, we submitted a pSB1C3 vector containing the "minimal Arc Gag" (derived from HIV-1 homology) construct to the registry. This construct was theorized and modeled by our team this year. The <i>Arc</i> DNA sequence, originally from <a href="https://www.uniprot.org/uniprot/Q63053" target="_blank">Rat</a> was compared to the HIV-1 DNA sequence due to Arc's relationship to retrotransposons. This part is theorized to retain its abilities to form capsid structures and deliver RNA to cells. Our results can be found <a href= "https://2018.igem.org/Team:Lethbridge/Results>here</a> and the full design of this part can be found <a href= "https://2018.igem.org/Team:Lethbridge/Design">here</a>.
−
<p> <a href="http://parts.igem.org/Part:BBa_K2683009">BBa_K2683009</a></p>
+
We hope to finish cloning all of our designed parts for future studies and applications.</p>
 +
</div>
 +
</div>
 +
 
 +
<div style="clear: both"></div>
 +
 
 +
<div><p class="f12" style="text-align: center"><a href="http://parts.igem.org/Part:BBa_K2683009"target="_blank">BBa_K2683009</a></p></div>
 +
 
 +
<div style="clear: both"></div><br><br>
 
      
 
      
−
    <h1>Basic Parts:</h1>
+
<h1>Basic and Composite Parts:</h1>
−
    <p>All of our new parts can be found on the <a href= "https://2018.igem.org/Team:Lethbridge/Basic_Part">basic parts</a> page and have been placed on the iGEM registry. These contain the four protein nanocompartments and the various cargo proteins and external surface modifiers.  
+
<div class="oneText-Wrapper">
−
</p>
+
<div class="oneText-Text">
 +
<p class="f12">All of our new parts can be found on the <a href= "https://2018.igem.org/Team:Lethbridge/Basic_Part"target="_blank">basic parts</a> page and have been placed on the iGEM registry. These contain the four protein nanocompartments and the various cargo proteins and external surface modifiers.</p>
 +
</div>
 +
</div>
 +
 
 +
<div style="clear: both"></div>
 +
 
 +
<div class="oneText-Wrapper">
 +
<div class="oneText-Text">
 +
<p class="f12"> This year we have designed 9 <a href="https://2018.igem.org/Team:Lethbridge/Composite_Part"target="_blank">composite parts</a> consisting of 4 capsid proteins with surface modifiers, cargoes with specific modifications for encapsulation and an external part for the surface modification of the P22 capsid. Each composite part has the same design, consisting of the T7 inducible promoter (<a href="http://parts.igem.org/Part:BBa_I712074"target="_blank" >BBa_I712074</a>), a medium strength RBS (<a href="http://parts.igem.org/Part:BBa_J61100"target="_blank">BBa_J61100</a>) and a double terminator (<a href="http://parts.igem.org/Part:BBa_B0014" target="_blank">BBa_B0014</a>).</p>
 +
</div>
 +
</div>
  
−
<P> This year we have designed 9 <a href="https://2018.igem.org/Team:Lethbridge/Composite_Part">composite parts</a> consisting of 4 capsid proteins with surface modifiers, cargoes with specific modifications for encapsulation and an external part for the surface modification of the P22 capsid. Each composite part has the same design, consisting of the T7 inducible promoter <a href="http://parts.igem.org/Part:BBa_I712074" >(BBa_I712074)</a>, a medium strength RBS <a href="http://parts.igem.org/Part:BBa_B0034">(BBa_B0034)</a>  and a double terminator <a href="http://parts.igem.org/Part:BBa_B0015" >(BBa_B0015|)</a>
+
<div style="clear: both"></div>
−
</P>
+
 
      
 
      
−
<h1> Improved Parts</h1>
+
<h1>Improved Parts:</h1>
−
     <p>As our system deals with the encapsulation of specific cagos one of our future applications is the encapsulation of Cell Free systems. Therefore we are pleased to say that our continuing work with last years project, Next Vivo, will allow us to encapsulate our <a href="https://2017.igem.org/Team:Lethbridge" >cell free system </a>. Since last years Jamboree we have been able to clone and characterize 15 more parts and will now submit them to the registry as improved parts. These parts include a his tag on the N or C terminus for purification and follow the general design of a T7 promoter <a href="http://parts.igem.org/Part:BBa_I719005" >(BBa_I719005)</a>, RBS <a href="http://parts.igem.org/Part:BBa_B0034">(BBa_B0034)</a> and Double terminator <a href="http://parts.igem.org/Part:BBa_B0015" >(BBa_B0015)</a>.</p>
+
<div class="oneText-Wrapper">
 +
<div class="oneText-Text">
 +
     <p class="f12">As our system deals with the encapsulation of specific cagos one of our future applications is the encapsulation of Cell Free systems. Therefore we are pleased to say that our continuing work with last years project, Next Vivo, will allow us to encapsulate our <a href="https://2017.igem.org/Team:Lethbridge"target="_blank" >cell free system</a>. Since last years Jamboree we have been able to clone and characterize 15 more parts and will now submit them to the registry as improved parts. These parts include a his tag on the N or C terminus for purification and follow the general design of a T7 promoter (<a href="http://parts.igem.org/Part:BBa_I719005"target="_blank" >BBa_I719005</a>), RBS (<a href="http://parts.igem.org/Part:BBa_B0034"target="_blank">BBa_B0034</a>) and Double terminator (<a href="http://parts.igem.org/Part:BBa_B0015"target="_blank" >BBa_B0015</a>).</p>
 +
</div>
 +
</div>
  
 +
<div style="clear: both"></div>
 +
 +
<center>
 
   <table style="width:60%"
 
   <table style="width:60%"
−
       <tr>
+
       <tr class="f12">
−
             <th>Biobrick Number</th><th>Part Name</th>
+
             <th>Biobrick Number</th>
 +
            <th>Part Name</th>
 
     </tr>
 
     </tr>
−
     <tr>
+
     <tr class="f11">
−
         <td><a href="http://parts.igem.org/Part:BBa_K2683016">BBa_K2683016</a></td>
+
         <td><a href="http://parts.igem.org/Part:BBa_K2683016"target="_blank">BBa_K2683016</a></td>
 
         <td>Release Factor 1</td>
 
         <td>Release Factor 1</td>
 
     </tr>
 
     </tr>
−
     <tr>
+
     <tr class="f11">
−
         <td><a href="http://parts.igem.org/Part:BBa_K2683017">BBA_K2683017</a></td>
+
         <td><a href="http://parts.igem.org/Part:BBa_K2683017"target="_blank">BBA_K2683017</a></td>
 
         <td>Release Factor 2</td>
 
         <td>Release Factor 2</td>
 
     </tr>
 
     </tr>
−
     <tr>  
+
     <tr class="f11">  
−
         <td><a href="http://parts.igem.org/Part:BBa_K2683018">BBa_K2683018</a></td>
+
         <td><a href="http://parts.igem.org/Part:BBa_K2683018"target="_blank">BBa_K2683018</a></td>
 
         <td> Cysteine tRNS Synthetase (CysRS)</td>
 
         <td> Cysteine tRNS Synthetase (CysRS)</td>
 
     </tr>
 
     </tr>
−
     <tr>
+
     <tr class="f11">
−
         <td> <a href="http://parts.igem.org/Part:BBa_K2683019" >BBa_K2683019</a></td>
+
         <td> <a href="http://parts.igem.org/Part:BBa_K2683019" target="_blank">BBa_K2683019</a></td>
 
         <td>Lysine tRNA Synthetase (LysRS)</td>
 
         <td>Lysine tRNA Synthetase (LysRS)</td>
 
     </tr>
 
     </tr>
−
     <tr>
+
     <tr class="f11">
−
         <td> <a href="http://parts.igem.org/Part:BBa_K2683020">BBa_K2683020</a></td>
+
         <td> <a href="http://parts.igem.org/Part:BBa_K2683020"target="_blank">BBa_K2683020</a></td>
 
         <td>Phenylalanine tRNA Synthetase alpha subunit (PheRS alpha)</td>
 
         <td>Phenylalanine tRNA Synthetase alpha subunit (PheRS alpha)</td>
 
     </tr>
 
     </tr>
−
     <tr>
+
     <tr class="f11">
−
         <td> <a href="http://parts.igem.org/Part:BBa_K2683021">BBa_K2683021</a></td>
+
         <td> <a href="http://parts.igem.org/Part:BBa_K2683021"target="_blank">BBa_K2683021</a></td>
 
         <td>Serine tRNA Synthetase (SerRS)</td>
 
         <td>Serine tRNA Synthetase (SerRS)</td>
 
     </tr>
 
     </tr>
−
     <tr>
+
     <tr class="f11">
−
         <td> <a href="http://parts.igem.org/Part:BBa_K2683022">BBa_K2683022</a></td>
+
         <td> <a href="http://parts.igem.org/Part:BBa_K2683022"target="_blank">BBa_K2683022</a></td>
 
         <td>Tryptophan tRNA Synthetase (TrpRS)</td>
 
         <td>Tryptophan tRNA Synthetase (TrpRS)</td>
 
     </tr>
 
     </tr>
−
     <tr>
+
     <tr class="f11">
−
         <td><a href="http://parts.igem.org/Part:BBa_K2683023">BBa_K2683023</a></td>
+
         <td><a href="http://parts.igem.org/Part:BBa_K2683023"target="_blank">BBa_K2683023</a></td>
 
         <td>Valine tRNA Synthetase (ValRS)</td>
 
         <td>Valine tRNA Synthetase (ValRS)</td>
 
     </tr>
 
     </tr>
−
     <tr>
+
     <tr class="f11">
−
         <td><a href="http://parts.igem.org/Part:BBa_K2683024">BBa_K2683024</a></td>
+
         <td><a href="http://parts.igem.org/Part:BBa_K2683024"target="_blank">BBa_K2683024</a></td>
 
         <td>Inititation Factor 1</td>
 
         <td>Inititation Factor 1</td>
 
     </tr>
 
     </tr>
−
     <tr>
+
     <tr class="f11">
−
         <td> <a href="http://parts.igem.org/Part:BBa_K2683025">BBa_K2683025</a></td>
+
         <td> <a href="http://parts.igem.org/Part:BBa_K2683025"target="_blank">BBa_K2683025</a></td>
 
         <td>Initiation Factor 3</td>
 
         <td>Initiation Factor 3</td>
 
     </tr>
 
     </tr>
−
     <tr>
+
     <tr class="f11">
−
         <td> <a href="http://parts.igem.org/Part:BBa_K2683026">BBa_K2683026</a></td>
+
         <td> <a href="http://parts.igem.org/Part:BBa_K2683026"target="_blank">BBa_K2683026</a></td>
 
         <td>Elongation Factor-Thermo Unstable (EF-Tu)</td>
 
         <td>Elongation Factor-Thermo Unstable (EF-Tu)</td>
 
     </tr>
 
     </tr>
−
     <tr><td><a href="http://parts.igem.org/Part:BBa_K2683027">BBa_K2683027</a></td>
+
     <tr class="f11">
 +
        <td><a href="http://parts.igem.org/Part:BBa_K2683027"target="_blank">BBa_K2683027</a></td>
 
         <td>Elongation Factor- Thermo Stable (EF-Ts)</td></tr>
 
         <td>Elongation Factor- Thermo Stable (EF-Ts)</td></tr>
−
     <tr><td><a href="http://parts.igem.org/Part:BBa_K2683028" >BBa_K2683028</a></td>
+
     <tr class="f11">
−
        <td>MyoKinase (MK)</td></tr>
+
        <td><a href="http://parts.igem.org/Part:BBa_K2683028"target="_blank" >BBa_K2683028</a></td>
−
     <tr>
+
        <td>MyoKinase (MK)</td></tr>
−
    <td> <a href="http://parts.igem.org/Part:BBa_K2683029">BBa_K2683029</a></td>
+
     <tr class="f11">
−
        <td>Nucleoside Diphosphate Kinase (NDK)</td>
+
        <td> <a href="http://parts.igem.org/Part:BBa_K2683029"target="_blank">BBa_K2683029</a></td>
 +
        <td>Nucleoside Diphosphate Kinase (NDK)</td>
 
     </tr>
 
     </tr>
−
     <tr>
+
     <tr class="f11">
−
         <td> <a href="http://parts.igem.org/Part:BBa_K2683030">BBa_K2683030</a></td>
+
         <td> <a href="http://parts.igem.org/Part:BBa_K2683030"target="_blank">BBa_K2683030</a></td>
 
         <td>Peptidyl Prolyl Isomerase (PPiase)</td>
 
         <td>Peptidyl Prolyl Isomerase (PPiase)</td>
 
     </tr>
 
     </tr>
 +
</table>
 +
</center>
 +
<br><br>
 +
 +
<h1>Existing Parts on the Registry</h1>
 +
<div class="oneText-Wrapper">
 +
<div class="oneText-Text">
 +
    <p class="f12">For the design of our protein nanocompartments, we have utilized previous parts already found in the registry:</p>
 +
</div>
 +
</div>
 +
 +
<div style="clear: both"></div>
 +
 +
<center>
 +
<table style="width:60%">
 +
    <tr class="f12">
 +
        <th>Biobrick Number</th>
 +
        <th>Part</th>
 +
    </tr>
 +
    <tr class="f11">
 +
        <td><a href="http://parts.igem.org/Part:BBa_I712074" target="_blank" >BBa_I712074</a></td>
 +
        <td>T7 Promoter</td>
 +
    </tr class="f11">
 +
    <tr class="f11">
 +
        <td> <a href="http://parts.igem.org/Part:BBa_J61100" target="_blank">BBa_J61100</a></td>
 +
        <td>Medium strength ribosomal binding site</td>
 +
    </tr>
 +
    <tr class="f11">
 +
        <td><a href="http://parts.igem.org/Part:BBa_B0014" target="_blank" >BBa_B0014</a></td>
 +
        <td>Double Terminator</td>
 +
    </tr>
 +
</table>
 +
</center>   
 +
<br><br>
 +
   
 
      
 
      
 
</div> <!--this closes off the content div-->
 
</div> <!--this closes off the content div-->
 
</body>
 
</body>
 
</html>
 
</html>

Latest revision as of 04:00, 18 October 2018



Parts Banner Image


In order to explore the modularity and various applications of Protein Nanocompartments (PNCs), we have designed systems that have distinct PNCs, surface modifiers, and cargos. Most PNCs are designed to have a specific surface modifying feature and cargo that look at different encapsulation strategies that are specific to these specific PNCs.

Each PNC system covers distinct applications for Research use. Each of our PNC systems is described in detail on our design page.

There are several capsid proteins described in the registry, including the MS2 protein. Our project diversified the capsid proteins available on the registry and are designed as composite parts under control of a T7 inducible promoter (BBa_I712074) a medium strength RBS (BBa_J61100) and a double terminator (BBa_B0014).

Parts Submitted:

This year, we submitted a pSB1C3 vector containing the "minimal Arc Gag" (derived from HIV-1 homology) construct to the registry. This construct was theorized and modeled by our team this year. The Arc DNA sequence, originally from Rat was compared to the HIV-1 DNA sequence due to Arc's relationship to retrotransposons. This part is theorized to retain its abilities to form capsid structures and deliver RNA to cells. Our results can be found here. We hope to finish cloning all of our designed parts for future studies and applications.



Basic and Composite Parts:

All of our new parts can be found on the basic parts page and have been placed on the iGEM registry. These contain the four protein nanocompartments and the various cargo proteins and external surface modifiers.

This year we have designed 9 composite parts consisting of 4 capsid proteins with surface modifiers, cargoes with specific modifications for encapsulation and an external part for the surface modification of the P22 capsid. Each composite part has the same design, consisting of the T7 inducible promoter (BBa_I712074), a medium strength RBS (BBa_J61100) and a double terminator (BBa_B0014).

Improved Parts:

As our system deals with the encapsulation of specific cagos one of our future applications is the encapsulation of Cell Free systems. Therefore we are pleased to say that our continuing work with last years project, Next Vivo, will allow us to encapsulate our cell free system. Since last years Jamboree we have been able to clone and characterize 15 more parts and will now submit them to the registry as improved parts. These parts include a his tag on the N or C terminus for purification and follow the general design of a T7 promoter (BBa_I719005), RBS (BBa_B0034) and Double terminator (BBa_B0015).

Biobrick Number Part Name
BBa_K2683016 Release Factor 1
BBA_K2683017 Release Factor 2
BBa_K2683018 Cysteine tRNS Synthetase (CysRS)
BBa_K2683019 Lysine tRNA Synthetase (LysRS)
BBa_K2683020 Phenylalanine tRNA Synthetase alpha subunit (PheRS alpha)
BBa_K2683021 Serine tRNA Synthetase (SerRS)
BBa_K2683022 Tryptophan tRNA Synthetase (TrpRS)
BBa_K2683023 Valine tRNA Synthetase (ValRS)
BBa_K2683024 Inititation Factor 1
BBa_K2683025 Initiation Factor 3
BBa_K2683026 Elongation Factor-Thermo Unstable (EF-Tu)
BBa_K2683027 Elongation Factor- Thermo Stable (EF-Ts)
BBa_K2683028 MyoKinase (MK)
BBa_K2683029 Nucleoside Diphosphate Kinase (NDK)
BBa_K2683030 Peptidyl Prolyl Isomerase (PPiase)


Existing Parts on the Registry

For the design of our protein nanocompartments, we have utilized previous parts already found in the registry:

Biobrick Number Part
BBa_I712074 T7 Promoter
BBa_J61100 Medium strength ribosomal binding site
BBa_B0014 Double Terminator